Portola Pharmaceuticals, Inc.® (PTLA) today announced the presentation of a new analysis of data from an important subgroup of ANNEXA-4, the Company's ...
Wednesday, 22 May 2019
Portola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Spontaneous (Non-Traumatic) Intracranial Hemorrhage - Yahoo Finance
Portola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Spontaneous (Non-Traumatic) Intracranial Hemorrhage Yahoo Finance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment